These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23292975)

  • 81. Missing data in FFQs: making assumptions about item non-response.
    Lamb KE; Olstad DL; Nguyen C; Milte C; McNaughton SA
    Public Health Nutr; 2017 Apr; 20(6):965-970. PubMed ID: 27923414
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A Bayesian framework for health economic evaluation in studies with missing data.
    Mason AJ; Gomes M; Grieve R; Carpenter JR
    Health Econ; 2018 Nov; 27(11):1670-1683. PubMed ID: 29969834
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Analyzing clinical trial outcomes based on incomplete daily diary reports.
    Thomas N; Harel O; Little RJ
    Stat Med; 2016 Jul; 35(17):2894-906. PubMed ID: 26888661
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Statistical primer: how to deal with missing data in scientific research?
    Papageorgiou G; Grant SW; Takkenberg JJM; Mokhles MM
    Interact Cardiovasc Thorac Surg; 2018 Aug; 27(2):153-158. PubMed ID: 29757374
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Sensitivity analyses for partially observed recurrent event data.
    Akacha M; Ogundimu EO
    Pharm Stat; 2016; 15(1):4-14. PubMed ID: 26540016
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Addressing missing data in clinical studies of kidney diseases.
    Montez-Rath ME; Winkelmayer WC; Desai M
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1328-35. PubMed ID: 24509298
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Prevention and handling of missing data in clinical trials].
    Jiang ZW; Li CJ; Wang L; Xia JL
    Yao Xue Xue Bao; 2015 Nov; 50(11):1402-7. PubMed ID: 26911032
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Handling Missing Covariates in Conditional Mixture Models Under Missing at Random Assumptions.
    Sterba SK
    Multivariate Behav Res; 2014; 49(6):614-32. PubMed ID: 26735361
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Addressing missing data in clinical trials.
    Fleming TR
    Ann Intern Med; 2011 Jan; 154(2):113-7. PubMed ID: 21242367
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Bayesian sensitivity analysis of incomplete data: bridging pattern-mixture and selection models.
    Kaciroti NA; Raghunathan T
    Stat Med; 2014 Nov; 33(27):4841-57. PubMed ID: 25256610
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice.
    Mallinckrodt CH; Bell J; Liu G; Ratitch B; O'Kelly M; Lipkovich I; Singh P; Xu L; Molenberghs G
    Ther Innov Regul Sci; 2020 Mar; 54(2):353-364. PubMed ID: 32072593
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Practical approaches to minimize problems with missing quality of life data.
    Simes RJ; Greatorex V; Gebski VJ
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):725-37. PubMed ID: 9549819
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fast tipping point sensitivity analyses in clinical trials with missing continuous outcomes under multiple imputation.
    Gorst-Rasmussen A; Tarp-Johansen MJ
    J Biopharm Stat; 2022 Nov; 32(6):942-953. PubMed ID: 35653556
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Non-response models for the analysis of non-monotone non-ignorable missing data.
    Robins JM
    Stat Med; 1997 Jan 15-Feb 15; 16(1-3):21-37. PubMed ID: 9004381
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Propensity scores using missingness pattern information: a practical guide.
    Blake HA; Leyrat C; Mansfield KE; Seaman S; Tomlinson LA; Carpenter J; Williamson EJ
    Stat Med; 2020 May; 39(11):1641-1657. PubMed ID: 32103533
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Reparameterizing the pattern mixture model for sensitivity analyses under informative dropout.
    Daniels MJ; Hogan JW
    Biometrics; 2000 Dec; 56(4):1241-8. PubMed ID: 11129486
    [TBL] [Abstract][Full Text] [Related]  

  • 97. An Empirical Comparison of Statistical Methods for Missing Data in Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Trials for Chronic Pain and Lipid-Lowering Products.
    Gnang J; Kim Y; Ren Y; Travis J; Kim Y
    Ther Innov Regul Sci; 2020 Nov; 54(6):1416-1427. PubMed ID: 32500449
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A comparison of missing data methods for hypothesis tests of the treatment effect in substance abuse clinical trials: a Monte-Carlo simulation study.
    Hedden SL; Woolson RF; Malcolm RJ
    Subst Abuse Treat Prev Policy; 2008 Jun; 3():13. PubMed ID: 18522752
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Assessable and interpretable sensitivity analysis in the pattern graph framework for nonignorable missingness mechanisms.
    Zamanian A; Ahmidi N; Drton M
    Stat Med; 2023 Dec; 42(29):5419-5450. PubMed ID: 37759370
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Data Missingness Patterns in Homicide Datasets: An Applied Test on a Primary Data Set.
    Neuilly MA; Hsieh ML; Kigerl A; Hamilton ZK
    Violence Vict; 2020 Aug; 35(4):589-614. PubMed ID: 32788337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.